Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03598192Completed
Randomised, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Gia Dinh People Hospital. Primary endpoint: Consumption of sufentanil at 24 hours. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03598192.